insurance companies are suing over a shortfall in an
insurance companies are suing over a shortfall in an ObamaCare program that they say is damaging their businesses.
Republicans in Congress are plotting ways to block the Obama administration from paying insurance companies hundreds of millions of dollars as part of an ObamaCare program.
GOP lawmakers say they are looking at "a dozen" options - including a possible provision in the year-end spending bill - to prevent the administration from using an obscure fund within the Treasury Department to pay out massive settlements to insurers.
The insurance companies are suing over a shortfall in an ObamaCare program that they say is damaging their businesses.
Settling the cases could help insurers deal with losses on the ObamaCare marketplaces, but Republicans argue the move would be a "bailout" that would circumvent the will of Congress.
Whether federal officials will actually pursue the settlements is an open question.
Any settlement between the Justice Department and health insurers would likely come out of the so-called judgment fund, a pool within the Treasury that is typically used in federal legal disputes.
Lawyers for the House Energy and Commerce Committee are exploring whether the insurer settlements would comply with the law and if so, what kind of legislation could be passed to block it, said Rep. Morgan Griffith (R-Va.).
"We're looking at ways to deal with that issue - mechanisms, either legislatively or judicially," Griffith said. He said he has already reviewed some drafts of legislation that could go before the committee. "Eventually I think there's going to be a piece of legislation, but we want to get it right."
Sen. John Barrasso (Wyo.), a member of Senate Republican leadership, said that his party is considering inserting language into the year-end funding bill.
"There is a role for Congress to play," on the issue, Barrasso said. "You can't imagine that President Obama would sign such a law, so you're now talking about, do you try to include it in one of the end-of-the-year funding packages like we've done in the past."
At issue is an ObamaCare program called risk corridors, which was designed to cushion insurers against heavy losses in the early years of the law by shifting money from insurers faring better to those faring worse.
But nowhere near enough money has come in to cover the payouts, meaning insurers were left with a hole in their balance sheets on top of other ObamaCare-related problems they were already facing. Insurers paid $363 million into the program in the first year, far short of the $2.87 billion sought by insurers.
Some insurers have cited that shortfall as a reason they are withdrawing from ObamaCare marketplaces altogether this year. The absence of the funding has also taken a toll on the 23 state startup insurance companies, known as co-ops, established under ObamaCare. Only six of those co-ops remain in business.
Insurers could receive at least some of the money they say they are still owed through legal settlements with the administration.
Conservatives have condemned the use of the judgment fund as an attempt to get around Congress, which passed legislation in a funding bill in 2014 to limit the administration's ability to pay out money to insurers under the risk corridor program.
Federal officials have not given a clear signal on whether they intend to settle.
The Department of Justice filed motions to dismiss two of the insurer lawsuits last week, forcefully arguing that the government doesn't actually owe them any money because Congress has since passed legislation limiting the funds.
But a memo from the Centers for Medicare and Medicaid Services (CMS) last month raised alarm bells for Republicans by indicating that the administration is open to settling the lawsuits. "We are willing to begin such discussions at any time," the memo said.
After the memo, Griffith said his staff warned him: "This is the tip of the iceberg."
Similarly, acting CMS Administrator Andy Slavitt indicated at a hearing last month that his agency has spoken with DOJ about potential settlements.
Last month, 46 House Republicans, led by Rep. Robert Pittenger (N.C.), wrote to HHS Secretary Sylvia Mathews Burwell saying they are committed to "exhausting all legislative and judicial options" to block the settlements.
Ten insurers have filed lawsuits, according to documents provided to the Energy and Commerce Committee. About 175 insurers overall are owed money in the fund and could still take legal action.
Energy and Commerce Committee Chairman Fred Upton (R-Mich.) on Tuesday wrote to insurers that have sued over the risk corridor funds requesting a briefing for committee staff and copies of any emails they have had with the administration over potential settlements.
A spokeswoman for the committee said Wednesday "all options are on the table."
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
UST's Strategic Move Into Automotive's Future Wake up and smell the coffee, because UST is shaking up the automotive scene. They've just pulled off a major play by grabbing a majority stake in Italdesign. If that doesn't scream the next leap forward for the auto world, I don't know what does. UST isn't just buying a company; it's marrying Italdesign's legendary design...
Continue Reading
Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...
Continue Reading
A Technological Leap for French Rugby Innovation and precision in partnerships—those words don't usually pop up together when chatting about a rugby league. But here we are, discussing the TOP 14, the elite French rugby championship, pairing up with Segway Navimow. This brand, under the umbrella of Ninebot Limited (689009.SH), is stepping into the world of sports for...
Continue Reading
Decoding the RNA Revolution Ever heard of circular RNA (circRNA)? This ain't your typical strand of genetic code. Unlike their straight-laced, linear counterparts, these RNAs form a loop you can't just break. Picture them as the Kevlar vests of the RNA world—tough, resilient, and packing the promise of next-gen treatments in their covalent loops. Here we’ve got...
Continue Reading
A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...
Continue Reading
Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...
Continue Reading
Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...
Continue Reading
Breaking New Ground with EXCiPACT Certification Here's a tale unfolding in the high-stakes world of biotechnology—CelluPro, a standout in cell culture media, just snagged the EXCiPACT™ certification. This isn't just some fancy plaque for the wall. It's a stamp of approval that screams reliability in the global biomanufacturing supply scene. Why This Certification...
Continue Reading
A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...
Continue Reading
Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...
Continue Reading
Top 5 Most Recently Viewed Articles
Leadership Changes at STMicroelectronics Italy is contemplating a significant shift in leadership at STMicroelectronics as concerns about the company's direction and performance have surfaced. The Italian government is mulling over the possibility of replacing CEO Jean-Marc Chéry in light of perceived inadequate results, especially as the semiconductor industry continues...
Continue Reading
Introducing Tricoci Forward: A New Initiative for Aspiring Beauticians Tricoci University of Beauty Culture is thrilled to unveil Tricoci Forward, a groundbreaking program aimed at inspiring high school students interested in the beauty industry. This initiative not only welcomes budding talents but also cultivates an environment where creativity and ambition can...
Continue Reading
New Features in ezPaycheck for Enhanced Compliance The recent updates in ezPaycheck are here to support businesses in adapting to the changing landscape of tax regulations following the enactment of The One Big Beautiful Bill. This update comes as a critical resource that empowers small and mid-sized businesses, accountants, and payroll processors to remain compliant with...
Continue Reading
Unicycive Therapeutics and Their Upcoming Appearances Unicycive Therapeutics, Inc., a pioneering clinical-stage biotechnology company dedicated to developing innovative therapies for kidney disease, is poised to make a significant impact at two upcoming investment conferences. The company's Chief Executive Officer, Shalabh Gupta, M.D., will engage with investors, sharing...
Continue Reading
The Surging Algae Products Market: A Sustainable Alternative The algae products market is experiencing remarkable growth, showcasing its potential to transform nutrition and wellness. Originally considered a niche, algae have emerged as a key player in food, health, beauty, and pharmaceuticals. With a valuation projected to rise significantly, the market is anticipated to...
Continue Reading